Market Overview

Research and Markets: Chinese Markets for Cancer Treatment Drugs - Profiles Forecasts up to 2016 and 2021 Major Producers

Share:
DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/nxjlrh/chinese_markets) has announced the addition of the "Chinese Markets for Cancer Treatment Drugs" report to their offering.

China's demand for cancer treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers in China are profiled.

Key Topics Covered:

I. INTRODUCTION

II. BUSINESS ENVIRONMENT

III. CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

IV. CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

V. CANCER TREATMENT DRUGS MARKET OUTLOOKS

VI. MARKETING STRATEGIES

VII. CANCER TREATMENT DRUGS PROFILES AND DIRECTORY

LIST OF TABLES

LIST OF CHARTS

Companies Mentioned

GlaxoSmithKline China

Beijing Novartis Pharmaceutical Co.,Ltd

Lily China

Jiangsu Hengrui Medicine Co., Ltd

Sanofi-Synthelabo

Pfizer China

Bristol-Myers Squibb China

Schering (Nanjing) Pharmaceutical Ltd

Guizhou KAAY Pharmaceutical Co.,Ltd

For more information visit http://www.researchandmarkets.com/research/nxjlrh/chinese_markets

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

View Comments and Join the Discussion!